MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 102 filers reported holding MAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $95,409 | -32.1% | 30,628 | +0.0% | 0.00% | – |
Q2 2023 | $140,414 | -7.5% | 30,624 | -0.3% | 0.00% | – |
Q1 2023 | $151,849 | +104.7% | 30,707 | +125.6% | 0.00% | – |
Q4 2022 | $74,186 | -11.8% | 13,611 | -47.6% | 0.00% | – |
Q3 2022 | $84,084 | +37.8% | 26,000 | +100.0% | 0.00% | – |
Q2 2022 | $61,000 | -33.0% | 13,000 | 0.0% | 0.00% | – |
Q1 2022 | $91,000 | -31.1% | 13,000 | 0.0% | 0.00% | – |
Q4 2021 | $132,000 | – | 13,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |